A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents

NCT01143077 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Lurasidone HCl

Sponsor

Sumitomo Pharma America, Inc.